Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Thalidomide

EU orphan designation number: EU/3/00/009
Active ingredient: Thalidomide
Indication: Treatment of erythema nodosum leprosum (ENL) or type II lepra reactions
Sponsor: Pharmion France
6/8 boulevard Haussmann, 75009 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2001 Orphan designation EMEA/OD/017/00 (2000)4256 of 29/12/2000
06/11/2002 Transfer of orphan designation EMEA/OD/017/00/T/01 (2002)4307 of 05/11/2002
22/02/2007 Change of name and/or address of sponsor
06/11/2007 Change of name and/or address of sponsor
04/09/2008 Removal of orphan designation from Community Register